March 2022

Web-Based Program May Improve Symptom Control For Patients With Recurrent Ovarian Cancer

Posted on March 15, 2022 by Womens Cancer Care

Cancer Therapy Advisor (3/7, Mistry) reported that “a web-based program called ‘WRITE Symptoms’ can improve symptom control for patients with recurrent ovarian cancer, according to a study” that “enrolled 497 patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer who had 3 or more symptoms.” The study findings published in the Journal of Clinical Oncology revealed […]

Secondary Cytoreductive Surgery Resulting in Maximal Tumor Resection Improves Overall Survival In Recurrent Ovarian Cancer

Posted on March 2, 2022 by Womens Cancer Care

MedPage Today (2/23, Bankhead) reported, “Secondary cytoreductive surgery (SCS) for recurrent ovarian cancer significantly improved overall survival…when surgery achieved maximal tumor resection, a large meta-analysis showed.” According to the results published in the Journal of Clinical Oncology, “pooled data from 36 studies showed a death rate of 44.2%, which decreased substantially with increasing rates of complete and optimal SCS.” […]